A previous study that used a chemical carcinogenesis protocol (DMBA/TPA) demonstrated that SCC cells enriched for CD34 more effectively produce secondary tumours upon transplantation compared to the CD34-negative cells 18. Here, CD34 is linked to neoplasm.